title: Drugs, money, and power: the Canadian drug shortage.
abstract: This article describes the shortage of generic injectable medications in Canada that affected hospitals in 2012. It traces the events leading up to the drug shortage, the causes of the shortage, and the responses by health administrators, pharmacists, and ethicists. The article argues that generic drug shortages are an ethical problem because health care organizations and governments have an obligation to avoid exposing patients to resource scarcity. The article also discusses some options governments could pursue in order to secure the drug supply and thereby fulfill their ethical obligations.
authors.affiliation: Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, A1B 3V6, Canada, christopher.kaposy@med.mun.ca.
authors.forename: Chris
authors.initials: C
authors.lastname: Kaposy
mesh_terms: D000927:Anticonvulsants / Q000191:economics / Q000600:supply & distribution; D002170:Canada; D004345:Drug Industry / Q000191:economics* / Q000941:ethics* / Q000331:legislation & jurisprudence / Q000639:trends; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution*; D015276:Health Care Rationing / Q000191:economics / Q000941:ethics; D019981:Health Care Sector / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D006761:Hospitals / Q000941:ethics; D006801:Humans; D007267:Injections; D007880:Legislation, Drug / Q000592:standards / Q000639:trends; D010594:Pharmacies / Q000191:economics / Q000941:ethics; D010634:Phenobarbital / Q000191:economics / Q000600:supply & distribution; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000927:Anticonvulsants; D016568:Drugs, Generic; D010634:Phenobarbital